Table 2

Patient characteristics by treatment group.

VariableNonoperative (n = 117)Single Fusion (n = 4)Multilevel Fusion (n = 28)Corpectomy (n = 12)Delayed Surgery (n = 5) P Value
Age, y, mean (SD)57.2 (20)47 (10.4)44 (18.4)46.5 (15.6)48.6 (6.9)0.010
Sex
 Men57 (48.7%)2 (50%)19 (67.9%)8 (66.7%)1 (20%)0.170
 Women60 (51.3%)2 (50%)9 (32.1%)4 (33.3%)4 (80%)
Body mass index, mean (SD)26.6 (6.9)28.5 (3.1)27.5 (4.9)26.4 (3.6)27 (6.1)0.947
Level
 T116 (5.1%)0 (0%)3 (10.7%)0 (0%)1 (20%)0.150
 T1224 (20.5%)2 (50%)8 (28.6%)3 (25%)3 (60%)
 L166 (56.4%)0 (0%)10 (35.7%)6 (50%)1 (20%)
 L221 (17.9%)2 (50%)7 (25%)3 (25%)0 (0%)
Smoker
 Never75 (64.1%)3 (75%)17 (60.7%)7 (58.3%)4 (80%)0.978
 Former14 (12%)0 (0%)2 (7.1%)2 (16.7%)0 (0%)
 Current28 (23.9%)1 (25%)9 (32.1%)3 (25%)1 (20%)
Placement
 Home73 (62.4%)3 (75%)20 (71.4%)9 (75%)3 (60%)0.834
 Rehabilitation44 (37.6%)1 (25%)8 (28.6%)3 (25%)2 (40%)
Neurologic deficit
 Intact117 (100%)4 (100%)26 (92.9%)9 (75%)5 (100%)0.001
 Deficit0 (0%)0 (0%)2 (7.1%)3 (25%)0 (0%)
Osteopenia/osteoporosis
 None73 (62.4%)4 (100%)22 (78.6%)9 (75%)5 (100%)0.729
 Osteopenia19 (16.2%)0 (0%)2 (7.1%)1 (8.3%)0 (0%)
 Osteoporosis25 (21.4%)0 (0%)4 (14.3%)2 (16.7%)0 (0%)
Corticosteroid use
 No108 (92.3%)4 (100%)26 (92.9%)12 (100%)5 (100%)>0.99
 Yes9 (7.7%)0 (0%)2 (7.1%)0 (0%)0 (0%)
  • Note: Data presented as n (%) unless otherwise indicated. Analysis of variance test conducted on all patient treatment groups with a significance threshold of P = 0.05 demonstrating when there is a significant difference in the mean between the groups.